Tau pathology and neurodegeneration

Area of Science:

• Neuroscience
• Genetics
• Pathology

Background:

• Tauopathies are neurodegenerative diseases linked to the tau protein pathway.
• Mutations in the MAPT gene cause inherited tauopathies, such as frontotemporal dementia and parkinsonism.
• Most tauopathies are not inherited, suggesting other mechanisms of disease initiation and spread.

Purpose of the Study:

• To investigate the mechanism of tau aggregation and propagation in neurodegenerative diseases.
• To understand the role of tau protein in the pathogenesis of tauopathies.
• To identify potential therapeutic targets for preventing tauopathy progression.

Main Methods:

• The study focuses on the transformation of tau protein from soluble to aggregated forms.
• It examines the prion-like, self-propagating nature of tau aggregate formation and spread.
• The research considers genetic factors, including mutations in the MAPT gene.

Main Results:

• Tau protein aggregation is central to human neurodegenerative tauopathies.
• Dysfunctional tau is sufficient to cause neurodegeneration and dementia.
• Tau aggregates spread in a prion-like manner, initiating in specific brain areas and propagating distantly.

Conclusions:

• Tauopathy pathogenesis involves the conversion of tau into aggregated, filamentous forms.
• The prion-like spread of tau aggregates is a key feature of these diseases.
• Targeting tau aggregation and propagation is a promising strategy for developing mechanism-based treatments.